Severe Chronic Neutropenia International Registry
严重慢性中性粒细胞减少症国际登记处
基本信息
- 批准号:10410150
- 负责人:
- 金额:$ 134.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-25 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAddressAdultAdvocacyAgeBacterial InfectionsBasic ScienceBibliographyBiocompatible MaterialsBioinformaticsBiologyBiometryBook ChaptersBostonCRISPR/Cas technologyCaringCase StudyChildhoodChronicClinicalClinical DataClinical MedicineClinical ResearchClinical TrialsClonal EvolutionCollaborationsColony-Stimulating Factor TherapyCommunicationCommunitiesComputational BiologyDataData AggregationData CollectionData SetDatabasesDevelopmentDiagnosisDiseaseEducationEducation and OutreachEvolutionFamilyFeedbackFosteringGeneticGenetic studyGenomicsGeographyGranulocyte Colony-Stimulating FactorHost DefenseHybridsImmunologic Deficiency SyndromesIndividualInfectionInformation TechnologyInfrastructureInnate Immune SystemInternationalLeukocytesLifeLinkMediatingMedicalMedical GeneticsModelingModernizationMolecularMolecular BiologyNational Institute of Allergy and Infectious DiseaseNatural HistoryNatural Language ProcessingNeutropeniaNewsletterPathogenesisPatient CarePatient EducationPatient Outcomes AssessmentsPatient advocacyPatient-Focused OutcomesPatientsPediatric HospitalsPhysiciansPilot ProjectsProviderPublished CommentPublishingRare DiseasesRecording of previous eventsRegistriesResearchResearch PersonnelResourcesRiskScienceSomatic MutationStudy modelsSupport GroupsSyndromeSystemTranslational ResearchTreatment outcomeUpdateWHIM syndromeWorkarmbaseclinical careclinical diagnosticsclinical phenotypecohortcomorbiditycomputerized data processingdata exchangedata integritydiagnostic tooldisease registryeditorialeducation resourceselastase inhibitorevidence baseexperiencefamily supportgene discoverygenomic datainnovationjournal articleknockout genemeetingsneutrophilnoveloperationoutreachpatient orientedrare conditionrecruitresponserisk stratificationsocial mediatechnology developmenttranslational approach
项目摘要
Project Summary / Abstract
Severe chronic neutropenia (SCN) is an immunodeficiency that leads to severe, often life-threatening,
infections in patients with both congenital and acquired forms of neutropenia. Despite granulocyte colony-
stimulating factor therapy, patients remain at long term, often life-long, risk of serious infections and additional
comorbidities. The Severe Chronic Neutropenia International Registry (SCNIR) was established in 1994 to
study the natural history and clinical consequences of SCN and its treatment. Based on the research resources
of the Registry, SCNIR investigators have published 255 journal articles, and 41 reviews and book chapters
related to SCN. The SCNIR has provided evidence-based clinical guidance, advanced our understanding of
neutrophil biology, and broadly informed the care of neutropenia and immunodeficiencies.
Scientific technology developments have opened new opportunities to investigate SCN biology. Ongoing
evolution of clinical medicine and diagnostics requires continued reassessment of natural history, treatments,
and outcomes. The objective of the SCNIR is to provide a platform to leverage innovations in database
science, molecular and computational biology, patient-reported outcomes, and other advances in
basic and clinical research to enable discovery of new treatments and inform medical management.
This project builds on the history of productive collaborations within and outside the SCNIR to expand available
NIAID resources and provide a model for the study of other immunodeficiencies and rare diseases. Our
SPECIFIC AIMS are:
Aim 1: Transition the SCNIR database to a hybrid model at Boston Children’s Hospital We will transition
SCNIR operations to Boston, with a hybrid data collection system engaging both physicians and patients;
collect and analyze patient-reported outcomes for SCN; and develop a pilot project in natural language
processing for data extraction and entry.
Aim 2: Generate clinically annotated genomic datasets for translational research in SCN We will characterize
the germline genomic features of chronic neutropenia for the study of genetic interactions, and novel genetic
causes of SCN by the research community; characterize the somatic mutational landscape of SCN; and
provide resources for innovative translational research and clinical trials.
Aim 3: Provide resources and outreach for education, recruitment, and retention.
The SCNIR will engage patients, families, and medical providers to provide education and promote retention
and will share expertise and foster collaborations with related patient advocacy and research groups.
Continued operation of this longstanding, productive registry will permit otherwise unfeasible long-term
assessments of SCN natural history, generate resources for both clinical and scientific research investigators,
and provide up-to-date educational resources and outreach to medical and patient communities.
项目总结/摘要
严重慢性中性粒细胞减少症(SCN)是一种免疫缺陷,导致严重的,往往危及生命,
先天性和获得性中性粒细胞减少症患者的感染。尽管有粒细胞集落-
刺激因子治疗,患者仍然处于长期的,通常是终身的,严重感染的风险和额外的
合并症。严重慢性中性粒细胞增多症国际登记处(SCNIR)成立于1994年,
研究SCN的自然史和临床后果及其治疗。基于研究资源
在登记处,SCNIR研究人员发表了255篇期刊文章,41篇评论和书籍章节
关于SCN SCNIR提供了循证临床指导,提高了我们对
中性粒细胞生物学,并广泛告知中性粒细胞减少症和免疫缺陷的护理。
科学技术的发展为研究SCN生物学提供了新的机会。正在进行
临床医学和诊断学的发展需要对自然史,治疗,
和结果。SCNIR的目标是提供一个平台,利用数据库创新
科学,分子和计算生物学,患者报告的结果,以及
基础和临床研究,以发现新的治疗方法,并为医疗管理提供信息。
该项目建立在SCNIR内外富有成效的合作历史的基础上,
NIAID资源,并为其他免疫缺陷和罕见疾病的研究提供了一个模型。我们
具体目标是:
目标1:在波士顿儿童医院将SCNIR数据库转换为混合模型
SCNIR操作到波士顿,具有医生和患者参与的混合数据收集系统;
收集和分析SCN的患者报告结果;并开发自然语言试点项目
用于数据提取和输入的处理。
目的2:生成用于SCN转化研究的临床注释基因组数据集
慢性中性粒细胞减少症的生殖系基因组特征,用于遗传相互作用的研究,以及新的遗传学
研究界提出的SCN的原因;描述SCN的体细胞突变景观;以及
为创新转化研究和临床试验提供资源。
目标3:为教育、征聘和留用提供资源和外联。
SCNIR将让患者、家庭和医疗服务提供者参与进来,提供教育并促进保留
并将分享专业知识,促进与相关患者倡导和研究团体的合作。
这一长期的、富有成效的登记册的继续运作将允许以其他方式不可行的长期
SCN自然史的评估,为临床和科学研究人员提供资源,
并提供最新的教育资源和推广到医疗和病人社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER E NEWBURGER其他文献
PETER E NEWBURGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER E NEWBURGER', 18)}}的其他基金
HOX cluster intergenic non-coding RNAs in myeloid differentiation and function
HOX簇基因间非编码RNA在骨髓分化和功能中的作用
- 批准号:
8435160 - 财政年份:2012
- 资助金额:
$ 134.51万 - 项目类别:
Novel Approach to Oral Gene Therapy for Chronic Granulomatous Disease
慢性肉芽肿性疾病口服基因治疗的新方法
- 批准号:
7740349 - 财政年份:2009
- 资助金额:
$ 134.51万 - 项目类别:
Novel Approach to Oral Gene Therapy for Chronic Granulomatous Disease
慢性肉芽肿性疾病口服基因治疗的新方法
- 批准号:
7806438 - 财政年份:2009
- 资助金额:
$ 134.51万 - 项目类别:
REG OF THE NADPH OXIDASE BY ANTI-INFLAMMATORY AGENTS
抗炎药对 NADPH 氧化酶的调节
- 批准号:
2631255 - 财政年份:1999
- 资助金额:
$ 134.51万 - 项目类别:
REG OF THE NADPH OXIDASE BY ANTI-INFLAMMATORY AGENTS
抗炎药对 NADPH 氧化酶的调节
- 批准号:
6394921 - 财政年份:1999
- 资助金额:
$ 134.51万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 134.51万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 134.51万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 134.51万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 134.51万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 134.51万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 134.51万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 134.51万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 134.51万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 134.51万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 134.51万 - 项目类别:
Research Grant